pan coronavirus T-cell vaccine

A **pan coronavirus T-cell vaccine** refers to a developmental vaccine candidate designed to induce broad cellular immunity against conserved coronavirus epitopes rather than narrowly strain-specific neutralizing antibody responses. In the specific identifiable usage located for this term, it describes a **preclinical lentiviral vector-based vaccine program from Theravectys** intended to target conserved coronavirus T-cell epitopes and provide broader protection against current and future coronavirus variants. The proposed mechanism is induction of antigen-specific T-cell responses, especially cytotoxic T-cell immunity, through presentation of conserved coronavirus antigens, with the goal of improving breadth and durability across variant or potentially multi-coronavirus threats. The term is partly generic rather than a clearly unique product name, so the exact construct, antigen set, formulation, and clinical development details are not fully specified from the available sources.

Other names

pan coronavirus T-cell vaccinepan-coronavirus T-cell vaccine candidate